Feedback / Questions
ateganosine (THIO) - MAIA Biotech
https://www.globenewswire.com/news-release/2025/12/11/3203966/0/en/MAIA-Biotechnology-Announces-First-Patient-Dosed-in-THIO-104-Phase-3-Pivotal-Trial-Evaluating-Ateganosine-as-Third-Line-Treatment-for-Advanced-Non-Small-Cell-Lung-Cancer.html
Dec 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next